Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Revitacare is a French aesthetic medicine and cosmetology company focused on the research, design, manufacture, and distribution of hyaluronic acid-based medical devices and sterile cosmetic products. Founded in 2003, the company markets injectable products for skin quality, facial rejuvenation, scalp and hair care, and dermal filling, with flagship brands including CYTOCARE and REVITAFILL. Its portfolio includes both cross-linked and non-cross-linked hyaluronic acid formulations used by medical doctors and aesthetic professionals. Revitacare operates internationally through distribution partners and has a meaningful commercial presence across dozens of countries. The company appears to be a commercial-stage healthcare business centered on aesthetic and skin-health products rather than a therapeutics-focused drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Revitacare.